Request Demo
Last update 16 Oct 2025
S-606001
Last update 16 Oct 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms S 606001, S606001 |
Target |
Action inhibitors |
Mechanism GYS1 gene inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with S-606001NCT07123155
A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Investigate the Safety, Pharmacodynamics, and Preliminary Efficacy of S-606001 as an Add-on to Enzyme Replacement Therapy in Patients With Late-onset Pompe Disease
JPRN-jRCT2071240030
A Phase 1, crossover, open-label study to compare the bioavailability of S-606001 between capsules and tablets and to investigate the food effect with the tablets following a single oral dose in healthy adults aged 18 to 55 years
100 Clinical Results associated with S-606001
Login to view more data
100 Translational Medicine associated with S-606001
Login to view more data
100 Patents (Medical) associated with S-606001
Login to view more data
100 Deals associated with S-606001
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glycogen Storage Disease Type II | Phase 2 | United States | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | Belgium | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | Denmark | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | France | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | Germany | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | Italy | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | Netherlands | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | Spain | 30 Oct 2025 | |
| Glycogen Storage Disease Type II | Phase 2 | United Kingdom | 30 Oct 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free